Clinical trial Recruiting at 1 site Interventional Ages 60 to 90

Determining the dietary tryptophan needs of older adults

Official title: The Tryptophan Requirement in Healthy Adults Over 60 Years

Run by The Hospital for Sick Children · NCT06283706 · Data updated 2026-11-12

This study is testing how much tryptophan older adults need in their diet to stay healthy and support their body's protein needs.

Quick facts

Study typeInterventional
Ages60 Years to 90 Years
SexAll
Enrollment40 (estimated)
SponsorThe Hospital for Sick Children
Academic / other
Locations1 site (Toronto, Ontario)
StatusRecruiting
StartedJune 1, 2024
Main results expectedJuly 1, 2025
Study endsDecember 1, 2025
Registry record updatedMay 30, 2025
Trial IDNCT06283706 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates for this study are healthy adults aged 60 to 90 years with a BMI under 30 who are willing to participate and provide consent.

Probably not a fit

Patients with chronic diseases or acute illnesses affecting protein metabolism, or those with significant dietary restrictions, may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This study investigates the dietary requirements for tryptophan, an essential amino acid, in healthy adults aged 60 to 90 years. Using the Indicator Amino Acid Oxidation method, the research aims to establish accurate tryptophan intake levels necessary for protein synthesis and overall health in older adults. Participants will undergo health assessments, including blood tests, to ensure they meet the eligibility criteria and can tolerate the dietary interventions. The findings will contribute to better dietary planning for the aging population.

Why it matters

Potential benefit: If successful, this study could lead to improved dietary guidelines that enhance the health and well-being of older adults.

How similar studies have gone: Previous studies have successfully determined amino acid requirements in different populations, suggesting that this approach may yield valuable insights for older adults as well.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Consent provided.
* Aged 60 to 90 years old.
* In good general health as evidenced by medical history, physical health and blood draw.
* Fasting blood glucose, hemoglobin A1c (HbA1c), urea, creatinine.
* Willingness to participate in the study.
* BMI \<30 kg/m2.

Exclusion Criteria:

* Presence of chronic disease and/or acute illness known to affect protein/amino acid metabolism (e.g. HIV, diabetes, taking medications known to affect protein/AA metabolism (e.g. steroids).
* Inability to tolerate the diet (i.e. allergy).
* Significant weight loss during the past month or consumption of weight reducing diets.
* Significant caffeine consumption (\>2 cups per day).
* Significant consumption of alcohol (\>1 drink per day i.e. 1 beer or ½ glass of wine).
* Unwilling to have blood drawn from a venous access or using a ventilated hood indirect calorimeter for the purposes of the study.

Where it's running

  • Hospital for Sick Children
    Toronto, Ontario, Canada
    Recruiting

Study contacts

  • Principal investigator: Glenda Courtney-Martin, PhD, RD — The Hospital for Sick Children
  • Study coordinator: Zhiyao Wang, MSc
  • Email: zhiyao.wang@sickkids.ca
  • Phone: 437 419 6224

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.